NCT06528496 2026-02-10N10: A Study of Reduced Chemotherapy and Monoclonal Antibody (mAb)-Based Therapy in Children With NeuroblastomaMemorial Sloan Kettering Cancer CenterPhase 2 Recruiting45 enrolled
NCT02176967 2025-12-22Response and Biology-Based Risk Factor-Guided Therapy in Treating Younger Patients With Non-high Risk NeuroblastomaChildren's Oncology GroupPhase 3 Active not recruiting621 enrolled